open5 visninger
India
IndiaBiopharma SHAKTI Mission 2026
A ₹10,000 crore flagship mission announced in Union Budget 2026-27 to position India as a global biotech and biopharma leader. The mission provides grants, equity support, and subsidised loans to biotech startups, MSMEs, and large pharma companies investing in vaccine development, biologics manufacturing, biosimilar production, and genomics research.
Hvem kan ansøge
Biotech and biopharma companies registered in India, startups registered with DPIIT, MSMEs in pharma/biotech sector, research institutions and academic spin-offs with technology readiness, large pharma companies for manufacturing scale-up in biosimilars, vaccines, cell & gene therapy.Fordele og Goder
- Grants
- Equity support
- Subsidised loans
Nøglekontakter
Sanket Ghogare
Editor
Kilder
Links brugt af AI til at indsamle information om dette legat.
- schemesinindia.in/central/biopharma-shakti-mission-india ↗
- birac.nic.in/ ↗
- pib.gov.in/PressNoteDetails.aspx?NoteId=157147&ModuleId=3®=3&lang=1 ↗
- economictimes.indiatimes.com/news/economy/policy/budget-2026-union-budget-2026-b… ↗
- static.pib.gov.in/WriteReadData/specificdocs/documents/2026/feb/doc202622776701.… ↗
- www.insightsonindia.com/2026/02/02/biopharma-shakti-initiative/ ↗